ZA884115B - 3,4-dihydro-2-alkyl-3-oxo-n aryl-2h-(1)benzothieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides - Google Patents

3,4-dihydro-2-alkyl-3-oxo-n aryl-2h-(1)benzothieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides

Info

Publication number
ZA884115B
ZA884115B ZA884115A ZA884115A ZA884115B ZA 884115 B ZA884115 B ZA 884115B ZA 884115 A ZA884115 A ZA 884115A ZA 884115 A ZA884115 A ZA 884115A ZA 884115 B ZA884115 B ZA 884115B
Authority
ZA
South Africa
Prior art keywords
alkyl
benzothieno
thiazine
carboxamide
dihydro
Prior art date
Application number
ZA884115A
Other languages
English (en)
Inventor
Anthony Marfat
Marfat Anthony
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA884115B publication Critical patent/ZA884115B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
ZA884115A 1987-06-10 1988-06-09 3,4-dihydro-2-alkyl-3-oxo-n aryl-2h-(1)benzothieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides ZA884115B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1987/001357 WO1988009793A1 (en) 1987-06-10 1987-06-10 3,4-DIHYDRO-2-ALKYL-3-OXO-N-ARYL-2H-[1]BENZOTHIENO[3,2-e]-1,2-THIAZINE-4-CARBOXAMIDE-1,1-DIOXIDES
EP88304975A EP0294994B1 (en) 1987-06-10 1988-06-01 3-4-Dihydro-2-alkyl-3-oxo-N-aryl-2H-[1]benzothieno[3,2-el]-1,2-thiazine-4-carboxamide-1,1-dioxides

Publications (1)

Publication Number Publication Date
ZA884115B true ZA884115B (en) 1990-02-28

Family

ID=55448100

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA884115A ZA884115B (en) 1987-06-10 1988-06-09 3,4-dihydro-2-alkyl-3-oxo-n aryl-2h-(1)benzothieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides

Country Status (28)

Country Link
US (1) US4914101A (no)
EP (1) EP0294994B1 (no)
JP (1) JPH078874B2 (no)
KR (1) KR900006758B1 (no)
CN (1) CN1019576B (no)
AT (1) ATE105561T1 (no)
AU (1) AU593743B2 (no)
CA (1) CA1300625C (no)
CZ (1) CZ281857B6 (no)
DD (1) DD281602A5 (no)
DE (1) DE3889497T2 (no)
DK (1) DK313388A (no)
EG (1) EG18525A (no)
ES (1) ES2051846T3 (no)
FI (1) FI89802C (no)
HU (1) HU203762B (no)
IE (1) IE63214B1 (no)
IL (1) IL86602A (no)
MX (1) MX174093B (no)
MY (1) MY103572A (no)
NO (2) NO176277C (no)
NZ (1) NZ224956A (no)
PH (1) PH25187A (no)
PL (1) PL158994B1 (no)
PT (1) PT87678B (no)
WO (1) WO1988009793A1 (no)
YU (1) YU46767B (no)
ZA (1) ZA884115B (no)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0455830B1 (en) * 1989-11-30 1996-06-26 Nippon Hypox Laboratories Incorporated Medicine containing thiazine dioxide derivative
US6340659B1 (en) 1995-12-13 2002-01-22 The Lubrizol Corporation Metal salts of lactones as lubricant additives
JP4250344B2 (ja) 2001-01-29 2009-04-08 インターナショナル・ビジネス・マシーンズ・コーポレーション ワークフローシステム、ワークフローサーバ、および記憶媒体
US8741299B2 (en) 2011-06-20 2014-06-03 The Feinstein Institute For Medical Research Method for treating pathologies associated with hypoxia using MIF inhibitors
US9666805B2 (en) * 2014-11-25 2017-05-30 Northwestern University Bithiophene sulfonamide-based molecular and polymeric semiconductors

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
CA1066711A (en) * 1974-08-26 1979-11-20 Hoffmann-La Roche Limited Thiophene derivatives
LU78009A1 (de) * 1977-08-22 1979-05-23 Hoffmann La Roche Verfahren zur herstellung von thiazinderivaten
AU518216B2 (en) * 1977-09-06 1981-09-17 Hafslund Nycomed Pharma Aktiengesellschaft Thienothiazine derivatives
DE2838377A1 (de) * 1978-09-02 1980-03-20 Thomae Gmbh Dr K Neue 4-hydroxy-2h eckige klammer auf 1 eckige klammer zu benzothieno eckige klammer auf 2,3-e eckige klammer zu -1,2- thiazin-3-carboxamid-1,1-dioxide sowie deren salze, deren verwendung und verfahren zu ihrer herstellung
ZA803401B (en) * 1979-06-13 1981-05-27 Hoffmann La Roche Thiazine derivatives
AU5811280A (en) * 1979-06-13 1980-12-18 F. Hoffmann-La Roche Ag Thiazine derivatives

Also Published As

Publication number Publication date
PL272928A1 (en) 1989-07-10
YU111988A (en) 1989-12-31
NO176277C (no) 1995-03-08
NO922636L (no) 1989-02-08
CZ392588A3 (en) 1996-11-13
ATE105561T1 (de) 1994-05-15
CN1019576B (zh) 1992-12-23
KR900006758B1 (ko) 1990-09-20
IL86602A0 (en) 1988-11-30
CZ281857B6 (cs) 1997-03-12
NO890531D0 (no) 1989-02-08
EP0294994A1 (en) 1988-12-14
EG18525A (en) 1994-04-30
NO890531L (no) 1989-02-08
YU46767B (sh) 1994-05-10
FI89802B (fi) 1993-08-13
NZ224956A (en) 1990-07-26
PL158994B1 (pl) 1992-10-30
IL86602A (en) 1992-06-21
NO176277B (no) 1994-11-28
DD281602A5 (de) 1990-08-15
CN88103539A (zh) 1988-12-28
CA1300625C (en) 1992-05-12
KR890000500A (ko) 1989-03-15
HUT54376A (en) 1991-02-28
PT87678A (pt) 1988-07-01
AU593743B2 (en) 1990-02-15
DE3889497D1 (de) 1994-06-16
AU1753588A (en) 1988-12-15
HU203762B (en) 1991-09-30
IE881733L (en) 1988-12-10
PT87678B (pt) 1992-10-30
DK313388A (da) 1988-12-11
IE63214B1 (en) 1995-04-05
DE3889497T2 (de) 1994-08-25
NO922636D0 (no) 1992-07-03
FI89802C (fi) 1993-11-25
JPS6413093A (en) 1989-01-17
MX174093B (es) 1994-04-21
US4914101A (en) 1990-04-03
PH25187A (en) 1991-03-27
EP0294994B1 (en) 1994-05-11
MX11827A (es) 1993-04-01
FI890620A (fi) 1989-02-09
JPH078874B2 (ja) 1995-02-01
WO1988009793A1 (en) 1988-12-15
DK313388D0 (da) 1988-06-09
ES2051846T3 (es) 1994-07-01
FI890620A0 (fi) 1989-02-09
MY103572A (en) 1993-08-28

Similar Documents

Publication Publication Date Title
AU7579094A (en) Methods for the treatment of peri-menopausal syndrome
AU2679684A (en) Naphthoquinone derivatives
IL86602A0 (en) 3,4-dihydro-2-alkyl-3-oxo-n-aryl-2h-(1)benzo-thieno(3,2-e)-1,2-thiazine-4-carboxamide-1,1-dioxides
JPS5321192A (en) Cephalosporin derivatives and their preparation
AU3421589A (en) Carbamoyl-2-pyrrolidinone compounds
ES2141096T3 (es) Compuestos de cefalosporina y composiciones farmaceuticas de los mismos.
AU1065788A (en) Dissolved composition of (benzo-1,2,4-thiadiazine)-1,1-dioxide
AU538882B2 (en) 2,3-dihydro-imidazo(1,2-g)pyridazine derivatives
EP0461574A3 (en) Medicines containing 3,7-diazabicyclo(3,3,1)nonanes
ES8605269A1 (es) Procedimiento para la fabricacion de derivados de tiadiazol activos sobre el sistema nervioso central
ES8602662A1 (es) Derivados de la 1, 4-dihidropiridina
ES8602785A1 (es) Procedimiento para preparar derivados de pirazolpiridina
JPS5430163A (en) 2-aminomethyl-5-phenyloxazoles and their pharmaceutically acceptable acid salts
AU566389B2 (en) (2,3-b) thieno pyrrole derivatives
ES8609254A1 (es) Un procedimiento para preparar un derivado de piridinodicar-boxilato
JPS5430168A (en) 2-(2-aminoethyl)-5-phenyloxazoles and their pharmaceutically acceptable acid salts